Spurious Drug Factory Busted In Gandhinagar

Ahmedabad: The Gujarat Food and Drug Administration (FDCA) raided a factory operating illegally within the Gujarat Industrial Development Corporation (GIDC) estate in Gandhinagar. The unit, owned by Bhavin Patel, was making medicines with a licence. The authorities suspect the factory was supplying “substandard and potentially harmful drugs across the state”, a press release from Gujarat FDCA said.

Gujarat FDCA commissioner H G Koshia said the raid unearthed a web of irregularities. Patel allegedly used fake production licences and did not have a qualified technician on the staff. Investigators suspect tablet fillers such as dibasic calcium phosphate (DCP) or starch were being used with no or improper active pharmaceutical ingredients (APIs) in medication that was sold as azithromycin, paracetamol, methylcobalamin (a vitamin B12 drug), pregabalin (analgesic) and thiocolchicoside (rheumatism drug).

“We found that they had replaced methylcobalamin, pregabalin and thiocolchicoside with DCP, starch or cheaper APIs and sold these spurious medicines. We have taken samples and are filing a case against them,” Koshia said.

Patel allegedly obtained fake production licences and GSTIN/UIN to set up the factory. “He procured the machinery to make tablets and capsules and had even secured a bank loan. Dummy pellets, empty capsule shells, omeprazole capsules, omeprazole pellets and maize starch powder were found at the factory,” Koshia added. The raid led to seizures of machinery, packaging material and counterfeit APIs, worth about Rs 4 crore.

Raw materials and finished products valued at Rs 43 lakh were also seized, the Gujarat FDCA statement said.

Related Posts

After two years, pharma volumes pick up pace

NEW DELHI: The domestic pharmaceutical retail market is showing its strongest signs yet of a shift from price-led to demand-led growth. Volume growth crossed 3% in June, the first time…

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

The National Pharmaceutical Pricing Authority (NPPA) has allowed an increase in the retail price of anti-rabies immunoglobulin while fixing the retail prices of 39 drug formulations.  According to a gazette…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

After two years, pharma volumes pick up pace

After two years, pharma volumes pick up pace

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

Tambaram police arrest two persons after seizing 1,100 banned tablets, 5 kg ganja

Tambaram police arrest two persons after seizing 1,100 banned tablets, 5 kg ganja

Rajasthan Healthcare Crisis: 8 Mothers Die Post-C-Section

Rajasthan Healthcare Crisis: 8 Mothers Die Post-C-Section

Steroid cream misuse fuels spurt in fungal infections

Steroid cream misuse fuels spurt in fungal infections

Dr Reddy’s delays semaglutide supplies due to API issue

Dr Reddy’s delays semaglutide supplies due to API issue